期刊文献+

新型降血压药奈必洛尔研究进展 被引量:11

The Progress in research of new antihypertensive,nebivolol
下载PDF
导出
摘要 奈必洛尔是新型选择性 β 受体阻滞剂 ,是一种兼有血管扩张作用的新型降压药物。主要介绍其药效学、药代动力学、疗效、耐受性和国内外对其合成工作的研究进展。 S,R,R,R)-nebivolol is a new type of selective β-adrenergic blocker,which has function about the expand of blood vessel for lower hypertension.The main study of nebivolol's pharmacodynamics,pharmacokinetics,therapeutic efficacy,tolerability and the progress of the synthesis research work were introduced in this text.
出处 《中国新药杂志》 CAS CSCD 北大核心 2003年第7期517-520,共4页 Chinese Journal of New Drugs
关键词 高血压 Β-受体阻滞剂 奈必洛尔 hypertension β-adrenergic blocker nebivolol
  • 相关文献

参考文献24

  • 1余海.奈必洛尔治疗原发性高血压[J].国外医药(合成药.生化药.制剂分册),1999,20(6):358-360. 被引量:2
  • 2黄震华.新型抗高血压药物奈必洛尔[J].中国新药杂志,2000,9(8):518-521. 被引量:8
  • 3马湘俊.β-受体阻滞剂在扩张型心肌病心力衰竭治疗中的应用[J].心脑血管病防治,2001,1(3):39-40. 被引量:1
  • 4苏哲坦.新一代β-阻滞剂的代表——Nebivolol[J].心血管病学进展,2000,21(6):369-370. 被引量:2
  • 5刘相星.新型β-阻滞剂奈必洛尔的临床降压效果(多中心研究结果)[J].心血管病学进展,2001,22(3):192-192.
  • 6王琼花.奈必洛尔首次在德国上市[J].World Pharm Newslett,1997,(8):23-23.
  • 7许英.奈必洛尔在英国上市[J].World Pharm Newslett,2000,(2):23-23.
  • 8Bridtow MR. What type of beta-blocker should be used to treat chronic heart failure[J]. Circulation ,2000,102(5) :484 - 486.
  • 9Kim MH,Devlin WH, Das SK, et al.Effects of beta-adrenergic blocking therapy on left ventricular diastolic relaxation properties in patients with dilated cardiomyopathy[ J ]. Circulation, 1999,100(7) : 729 - 735.
  • 10Metra M, Giubbini R, Nodari S, a d .Differential effects of betablockers in patients with heart failure: A prospective,randomized,double-blind comparison of the long-term effects of metoprolol versus carcvedilol[J].Circulation,2000,102(5):546-551

二级参考文献15

  • 1黄震华.兼有血管扩张作用的β受体阻滞剂[J].新药与临床,1989,8(3):154-157. 被引量:1
  • 2Parker M, Cohn Jn. On behalf of ACTION-HF; consensus recommendations for themanagement of chronic heart failure. Am J Cardiol, 1999, 83: 1A-38A.
  • 3Bristow MR. What type of beta-blocker should be used to treat chronic heartfailure? Circulation. 2000, 102 (5): 484~486.
  • 4Kim MH, Devlin WH, Das SK,et al. Effects of beta-adrenergic blocking therapy onleft ventricular diastolic relaxation properties in patients with dilated cardiomyopathy.Circulation, 1999, 100(7):729~735.
  • 5Di Lenarda A, Hlede S, Sabbadini G, et al. Improvement of prognosis in idiopathicdilated cardiomyopathy: role of early diagnosis and optimized medical treatment. StudyGroup on Heart Muscle Diseases. G Ital Cardiol, 1999, 29(12):1452~1462.
  • 6Metra M, Giubbini R, Nodari S, et al. Differential effects of beta-bolckers inpatients with heart failure:A prospective,randomized, double-blind compartison of thelong-term effects of metoprolol versus carvedilol. Circulation, 2000, 102(5):546~551.
  • 7Anthonio Rl, Brouwer J, Lechat P,et al. Different effects of bisoprolol on heart rate in patients with ischemic oridiopathic dilated cardiomyopathy (a 24-hour holter substudy) of the Cardiac InsufficiencyBisoprolol Study[DIBIS]. Am J Cardiol, 1999, 83(8):1286.
  • 8Kakuchi H, Sasaki T, Ishida-Y, et al. Clinical usefulness of 1231meta-iodobenzylguanidine imaging in predicting the effectiveness of beta blockers forpatients with idiopathic dilated cardiomyopathy before and soon after treatment. Heart,1999,81(2):148~152.
  • 9Jansson K, Hagerman I,Ostlund R,et la. The effects of metoprolol and captopril onheart rate variability in patients with idiopathic dilated cardiomyopathy. Clin Cardiol,1999, 22(6):397~402.
  • 10Toyama T, Aihara Y, Iwasaki T, et al. Cardiac sympathetic activity estimated by1231-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker orangiotensin-converting enzyme inhibitor therapy. J Nucl Med,1999, 40(2):217~223.

共引文献9

同被引文献50

  • 1杨运旭,王乃兴,盛瑞隆,张军平,于安光,汪武卫.6-氟-色满-2-羧酸的合成及其(R)-,(S)-光学异构体的拆分研究[J].有机化学,2005,25(2):201-203. 被引量:5
  • 2刘香,刘振,段更利.紫外分光光度法测定蜂胶搽剂中总黄酮的含量[J].贵阳医学院学报,2005,30(3):230-231. 被引量:9
  • 3陈鹏,陈钢,张开元,李鹏.盐酸奈必洛尔的合成[J].中国医药工业杂志,2006,37(5):289-292. 被引量:9
  • 4Imran A, Kishwar S, Vinay DG, et al. Chiral separations of some beta-adrenergic agonists and antagonists on amycoat column by HPLC [J]. Chirality ,2010,22 ( 1 ) :24 - 28.
  • 5Imran A, Aboul - Enein HY. Enantioseparation of some clinically used drugs by HPLC using cellulose tris ( 3,5 - dichlorophenyl- carbamate) chiral stationary phase [ J ]. Biomedical chromatography,2003,17(2) :113 -117.
  • 6Chaturvedi S. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) : is it really praetieal[J].Natl Med J India,2004,17(4) :227.
  • 7Water A V, Janssens W, Neuten J V, et al. Pharmacological and hemodynamic profile of nebivolol, a chemical novel, potent, and selective β1-adrenergic antagonist [J]. Journal of Cardiovascular Pharmacolouv, 1988, 11(5):552-553.
  • 8Kalinowski L, Dobrucki L W, Szczepanska K M, et al. Third-generation fl-blocker stimulate nitric oxide release from endothelial cell through ATP efflux[J].Circulation, 2003, 107(21):2747-2752.
  • 9Lommmen V, Bruyn D. Derivation of 2, 2'-iminobisethanol[P]. EP:0145067 A2, 1985.
  • 10Mathieu R, Lommen V. [iminobis-methylene]bis[3,4-dihydro-2H-1-benzopyran-2-methanol] derivations of formula[P]. EP:0334429A1, 1989.

引证文献11

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部